Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $401.74 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $171.55 | 2 | $0 (2018) |
| Servier Pharmaceuticals LLC | $119.10 | 1 | $0 (2019) |
| Celgene Corporation | $75.05 | 1 | $0 (2018) |
| PharmaEssentia USA Corporation | $24.45 | 1 | $0 (2023) |
| PFIZER INC. | $11.59 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.45 | 1 | PharmaEssentia USA Corporation ($24.45) |
| 2019 | $130.69 | 2 | Servier Pharmaceuticals LLC ($119.10) |
| 2018 | $246.60 | 3 | Novartis Pharmaceuticals Corporation ($171.55) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2023 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Oncology | ||||||
| 10/11/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/21/2019 | Servier Pharmaceuticals LLC | ONCASPAR (Drug) | Food and Beverage | In-kind items and services | $119.10 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $75.05 | General |
| Category: Hematology / Oncology | ||||||
| 12/01/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HEMATOLOGY | ||||||
| 11/30/2018 | Novartis Pharmaceuticals Corporation | ABL002 (Drug) | Food and Beverage | In-kind items and services | $46.55 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 66 | 131 | $45,575 | $8,625 |
| 2022 | 7 | 130 | 248 | $76,711 | $15,209 |
| 2021 | 9 | 276 | 714 | $198,060 | $44,776 |
| 2020 | 5 | 180 | 472 | $128,939 | $29,230 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 28 | $11,448 | $3,064 | 26.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 48 | $14,895 | $2,906 | 19.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 18 | 29 | $14,390 | $1,670 | 11.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 26 | $4,842 | $985.40 | 20.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 98 | $28,714 | $5,416 | 18.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 35 | $12,590 | $2,779 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 22 | $8,412 | $2,396 | 28.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 20 | 29 | $13,747 | $1,720 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 20 | $5,289 | $1,372 | 25.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 32 | $5,733 | $953.14 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 12 | $2,226 | $573.56 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 253 | $71,854 | $14,193 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 126 | $43,655 | $10,158 | 23.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 71 | $26,070 | $7,879 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 69 | $17,376 | $5,090 | 29.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 95 | $16,189 | $2,849 | 17.6% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 26 | 31 | $13,973 | $1,888 | 13.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 19 | 21 | $3,738 | $1,061 | 28.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 15 | $3,687 | $844.20 | 22.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 16 | 33 | $1,518 | $813.18 | 53.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 116 | $38,124 | $9,519 | 25.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 166 | $44,788 | $9,462 | 21.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 41 | 104 | $25,040 | $6,230 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 38 | 61 | $10,396 | $2,459 | 23.7% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 20 | 25 | $10,591 | $1,560 | 14.7% |
About Dr. James Thompson, MD
Dr. James Thompson, MD is a Hematology & Oncology healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568405868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Thompson, MD has received a total of $401.74 in payments from pharmaceutical and medical device companies, with $24.45 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($401.74).
As a Medicare-enrolled provider, Thompson has provided services to 652 Medicare beneficiaries, totaling 1,565 services with total Medicare billing of $97,840. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Buffalo, NY
- Active Since 06/14/2006
- Last Updated 02/11/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1568405868
Products in Payments
- TASIGNA (Drug) $125.00
- ONCASPAR (Drug) $119.10
- Revlimid (Drug) $75.05
- ABL002 (Drug) $46.55
- BESREMI (Drug) $24.45
- CHANTIX (Drug) $11.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Buffalo
Elizabeth Griffiths, Md, MD
Hematology & Oncology — Payments: $173,027
Grace Dy, Md, MD
Hematology & Oncology — Payments: $135,643
Philip Mccarthy, Md, MD
Hematology & Oncology — Payments: $83,897
Igor Puzanov, Md, MD
Hematology & Oncology — Payments: $70,626
Pallawi Torka, Md, MD
Hematology & Oncology — Payments: $33,647
Kannan Thanikachalam, M.b.b.s, M.B.B.S
Hematology & Oncology — Payments: $3,234